M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
about
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.
P2860
M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
M-CSF in a new biomarker panel ...... helial ovarian cancer patients
@ast
M-CSF in a new biomarker panel ...... helial ovarian cancer patients
@en
type
label
M-CSF in a new biomarker panel ...... helial ovarian cancer patients
@ast
M-CSF in a new biomarker panel ...... helial ovarian cancer patients
@en
prefLabel
M-CSF in a new biomarker panel ...... helial ovarian cancer patients
@ast
M-CSF in a new biomarker panel ...... helial ovarian cancer patients
@en
P2093
P2860
P1476
M-CSF in a new biomarker panel ...... helial ovarian cancer patients
@en
P2093
Ewa Gacuta
Maciej Szmitkowski
Przemysław Pawłowski
P2860
P2888
P356
10.1186/S13048-015-0153-3
P577
2015-05-03T00:00:00Z
P5875
P6179
1045222560